PRIMARY RESEARCH | PUBMED LINKS
DRUG CATEGORY: PEPTIDES+ (HGH SUPPORT)
DRUG NAME: IPAMORELIN

  • FDA Safety Data Sheet not available (experimental peptide therapy)

  • Sigalos J. The Safety and Efficacy of Growth Hormone Secretagogues. Sex Med Rev. 2018 [PubMed Link] 

  • Sinha DK. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Transl Androl Urol. 2020 [PubMed Link]

  • Smith RG. Development of growth hormone secretagogues. Endocr Rev. 2005 [PubMed Link]

  • Svensson J. Growth hormone secretagogues as therapeutic agents. Growth Horm IGF Res. 1999 [PubMed Link]

  • Sigalos JT. Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels. Am J Mens Health. 2017 [PubMed Link]

  • Lu Z. The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism. Physiol Behav. 2024 [PubMed Link]

  • Ferro P. Structure-activity relationship for peptídic growth hormone secretagogues. Drug Test Anal. 2017 [PubMed Link]

  • Thomas A. Metabolism of growth hormone releasing peptides. Anal Chem. 2012 [PubMed Link]

  • Peschke B. The influence of conformational restriction in the C-terminus of growth hormone secretagogues on their potency. Eur J Med Chem. 2002 [PubMed Link] 

  • Matsumoto M. Structural similarity of ghrelin derivatives to peptidyl growth hormone secretagogues. Biochem Biophys Res Commun. 2001 [PubMed Link]

  • Ahnfelt-Rønne I. Do growth hormone-releasing peptides act as ghrelin secretagogues?. Endocrine. 2001 [PubMed Link]

  • Lall S. Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues. Biochem Biophys Res Commun. 2001 [PubMed Link] 

  • Gobburu JV. Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Pharm Res. 1999 [PubMed Link]

  • Johansen PB. Pharmacokinetic evaluation of ipamorelin and other peptidyl growth hormone secretagogues with emphasis on nasal absorption. Xenobiotica. 1998 [PubMed Link]

  • Raun K. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998 [PubMed Link]